SETDB1 and Alzheimer disease: Given that EGR1 has been implicated in the pathological changes in AD and can be modulated by SET1/MLL and SETDB1 (ESET) through the methylation pathway, we hypothesize that the two histone methyltransferases may also influence the pathological progression of AD by affecting EGR1.